Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System

NCT: NCT07444320 · RECRUITING

NCT IDNCT07444320
StatusRECRUITING
Start Date2026-02-12
Completion2028-02

Brief Summary

This is a multicenter, prospective, single-arm, feasibility study to evaluate the safety and effectiveness of the waveforms being delivered using the FARAPULSE PFA System in patients with Paroxysmal Atrial Fibrillation (PAF) and Persistent Atrial Fibrillation (PersAF).

Frequently Asked Questions

What is Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System?

Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System is a clinical trial registered under NCT07444320. Current status: RECRUITING.

What is the status of NCT07444320?

The current status of NCT07444320 (Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System) is: RECRUITING.

When did Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System start?

Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System started on 2026-02-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑